Astellas Pharma Ltd.
基本情報
- 所在地
- 東京
- 社長
- 岡村直樹
- 資本金
- 15,000,000,000 円 (150 億円)
- 従業員数(単独)
- 従業員数(連結)
- 開始日
- 終了日
サイト
事業内容
関連会社
| 会社名 | Group | 親会社 | 子会社 | 得意先 | 仕入先 | 業務提携 | 銀行等 | 株主等 |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
| Avara Norman Pharmaceutical Services, Inc. | ||||||||
| Nippon Medical & Pharmaceutical Co., Ltd. | ||||||||
| 武田薬品工業株式会社 |
関連図
沿革
Yakult Honsha was renamed to Yakult Honsha Co., Ltd. in 1940
In 1942, the headquarters was relocated to Tokyo
Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy.
Leaders of Yakult Honsha and Fujisawa Pharmaceutical exchanged handshakes to commemorate the merger in 2005. This merger led to the founding of Astellas, which developed a global strategy centered on patients. Astellas was established through the merger of Yakult Honsha, founded in 1923, and Fujisawa Pharmaceutical, founded in 1894, in April 2005.
Astellas was established in April 2005 through the merger of two companies – Yamanouchi Pharmaceutical (founded in 1923) and Fujisawa Pharmaceutical (founded in 1894).
Astellas Pharma celebrated its 20th anniversary in April 2025.
In April 2025, Astellas celebrated our 20th Anniversary as a company.
ニュース
ニュースはありません。